Skip to Content
Merck
  • Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer.

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer.

Data in brief (2017-03-16)
Zachary A P Wintrob, Jeffrey P Hammel, George K Nimako, Dan P Gaile, Alan Forrest, Alice C Ceacareanu
PMID28289695
ABSTRACT

Oral drugs stimulating insulin production may impact growth factor levels. The data presented shows the relationship between pre-existing insulin secretagogues use, growth factor profiles at the time of breast cancer diagnosis and subsequent cancer outcomes in women diagnosed with breast cancer and type 2 diabetes mellitus. A Pearson correlation analysis evaluating the relationship between growth factors stratified by diabetes pharmacotherapy and controls is also provided.